ArticleTheranostics2026

Characterization and validation of a bone metastatic castration-resistant prostate cancer model as a nanomedicine evaluation platform.

Antoni Serrano-Martí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.